Bristol-Myers Squibb Stock Forecast
NYSE: BMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BMY analyst consensus
Consensus (28 analysts)
hold
Avg. price target
$66.17+11.92%
- Strong buy 3
- Buy 6
- Hold 18
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 28 Wall Street analysts covering Bristol-Myers Squibb (2026-10-07), 9 rate the stock a buy or strong buy, 18 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $66.17, with a high estimate of $82.00 and a low estimate of $41.00. The average target implies upside of 11.9% from the current price of $59.12.
The spread between the highest and lowest targets is 100.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BMY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 11% |
| Buy | 6 | 21% |
| Hold | 18 | 64% |
| Sell | 1 | 4% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $41.00 | -30.65% |
| Average target | $66.17 | +11.92% |
| High target | $82.00 | +38.70% |